Jasper Therapeutics JSPR
NASDAQ JSPR
$0.70 +0.01 (+2.02%)
At close: Sep 10, 2026 · 4:00 PM EDT

Jasper Therapeutics (JSPR) Treasury Shares (2019 - 2026)

Jasper Therapeutics (JSPR) posted Treasury Shares of $550000.0 for Q2 2026, little changed on a QoQ basis from $550000.0 in Q4 2025, and little changed year-over-year from $550000.0 in Q2 2025.

Analysis

Jasper Therapeutics (JSPR) Treasury Shares (2019 - 2026) Analysis & Trends

Jasper Therapeutics has reported Treasury Shares for 7 years, with the latest figure at $550000.0 in Q2 2026.

  • On a quarterly basis, Treasury Shares changed 0.0% year-over-year to $550000.0 in Q2 2026; TTM through Jun 2026 was $550000.0, a 0.0% change from a year earlier, with the FY2025 full-year figure at $550000.0, changed 0.0% from the prior year.
  • Treasury Shares was $550000.0 for Q2 2026 at Jasper Therapeutics, roughly flat from $550000.0 in the prior quarter.
  • The five-year high for Treasury Shares was $5.5 million in Q3 2023, with the low at $550000.0 in Q4 2023.
  • Average Treasury Shares over 4 years is $1.0 million, with a median of $550000.0 recorded in 2023.
  • The largest YoY upside for Treasury Shares was 0.0% in 2024 against a maximum downside of 90.0% in 2024.
  • Over 4 years, Treasury Shares stood at $550000.0 in 2023, then changed by 0.0% to $550000.0 in 2024, then changed by 0.0% to $550000.0 in 2025, then changed by 0.0% to $550000.0 in 2026.
  • The last three Treasury Shares figures came in at $550000.0 (Q2 2026), $550000.0 (Q4 2025), and $550000.0 (Q3 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Treasury Shares (Qtr)
1 Amgen 206.44 Bn 192.45 Bn 7.24 Bn -
2 Gilead Sciences 179.97 Bn 176.79 Bn 6.22 Bn -
3 Vertex Pharmaceuticals 130.57 Bn 122.72 Bn 2.84 Bn -
4 Regeneron Pharmaceuticals 81.63 Bn 73.63 Bn 3.93 Bn 36.40 Mn
5 Argenx Se 60.34 Bn 55.16 Bn 1.37 Bn -
6 Moderna 54.37 Bn 49.23 Bn 52.00 Mn -
7 Alnylam Pharmaceuticals 33.07 Bn 29.76 Bn 992.69 Mn -
8 Biogen 31.84 Bn 30.55 Bn 1.96 Bn -23.80 Mn
9 Roivant Sciences 29.49 Bn 29.49 Bn 1.16 Mn -
10 Jasper Therapeutics 20.11 Mn 20.11 Mn - 550,000.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 550,000.00
Jun 30, 2026 550,000.00
Dec 31, 2025 550,000.00
Dec 31, 2025 550,000.00
Sep 30, 2025 550,000.00
Sep 30, 2025 550,000.00
Jun 30, 2025 550,000.00
Jun 30, 2025 550,000.00
Mar 31, 2025 550,000.00
Mar 31, 2025 550,000.00
Dec 31, 2024 550,000.00
Dec 31, 2024 550,000.00
Sep 30, 2024 550,000.00
Sep 30, 2024 550,000.00
Jun 30, 2024 550,000.00
Jun 30, 2024 550,000.00
Mar 31, 2024 550,000.00
Mar 31, 2024 550,000.00
Dec 31, 2023 550,000.00
Dec 31, 2023 550,000.00